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Noor Tromp1*, Charlotte Michels1, Evelinn Mikkelsen1, Jan Hontelez1,2 and Rob Baltussen1Abstract
Introduction: About half a million people in South Africa are deprived of antiretroviral therapy (ART), and there is
little systematic knowledge on who they are – e.g. by severity of disease, sex, or socio-economic status (SES). We
performed a systematic review to determine the current quantitative evidence-base on equity in utilization of ART
among HIV-infected people in South Africa.
Method: We conducted a literature search based on the Cochrane guidelines. A study was included if it compared for
different groups of HIV infected people (by sex, age, severity of disease, area of living, SES, marital status, ethnicity, religion
and/or sexual orientation (i.e. equity criteria)) the number initiating/adhering to ART with the number who did not. We
considered ART utilization inequitable for a certain criterion (e.g. sex) if between groups (e.g. men versus women)
significant differences were reported in ART initiation/adherence.
Results: Twelve studies met the inclusion criteria. For sex, 2 out of 10 studies that investigated this criterion found that
men are less likely than women to utilize ART, while the other 8 found no differences. For age, 4 out of 8 studies found
inequities and reported less utilization for younger people. For area of living, 3 out of 4 studies showed that those living
in rural areas or certain provinces have less access and 2 out of 6 studies looking at SES found that people with lower
SES have less access. One study which looked at the marital status found that those who are married are less likely to
utilize ART. For severity of disease, 5 out of 6 studies used more than one outcome measure for disease stage and
reported within their study contradicting results. One of the studies reported inconclusive findings for ethnicity and
no study had looked at religion and sexual orientation.
Conclusion: It seems that men, young people, those living in certain provinces or rural areas, people who are
unemployed or with a low educational level, and those being unmarried have less access to ART. As studies stem
from different contexts and use different methods conclusions should be taken with caution.
Keywords: Antiretroviral therapy, Equity, South Africa, Systematic reviewIntroduction
South Africa is home to the largest HIV-infected popula-
tion worldwide, with 6.1 million people living with HIV/
AIDS in 2012 [1]. The country also has the largest anti-
retroviral therapy (ART) program worldwide: with do-
mestic investments amounting to US$1.9 billion in 2011
[2], it provided treatment to about 80% (2.0 million
people) of all eligible people in 2012 [1]. Current South* Correspondence: noor.tromp@radboudumc.nl
1Department of Primary and Community Care, Radboudumc, Nijmegen,
The Netherlands
Full list of author information is available at the end of the article
© 2014 Tromp et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orAfrican guidelines state that all those with CD4 cell
counts of ≤350 cells/μL are eligible for ART [3].
Nevertheless, a significant treatment gap of about half
a million people remains between those who receive
treatment and those in need according to the eligibility
criteria [1]. There is little knowledge on which people
are deprived from treatment – e.g. by severity of disease,
sex, age, socio-economic status (SES) and area of living
[4], limiting the development of policy measures to spe-
cifically target and improve treatment coverage among
these groups. This is illustrated in South Africa’s ‘Na-
tional Strategic Plan on HIV, STIs and TB 2012-2016’Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Tromp et al. International Journal for Equity in Health 2014, 13:60 Page 2 of 17
http://www.equityhealthj.com/content/13/1/60which flags the importance of inequalities in treatment
utilization but is not specific on which marginalized
groups should be targeted [5].
It is clear that ART not only improves a patient’s
health and survival [6,7], but also substantially reduces
their infectiousness [8,9]. As a result, ART can play an
important role in controlling the epidemic in South
Africa [10-12]. The World Health Organization (WHO)
recently released new consolidated guidelines, taking
both the prevention and treatment benefits of ART into
account [13,14]. The new guidelines state that ART
should be provided for HIV infected people with a CD4
cell count of ≤500 cells/μL, who are in a serodiscordant
relationship, and/or pregnant [14]. In addition, the
WHO also states that guidelines should be expanded
when universal access for those with CD4 cell counts
of ≤350 cells/μL has already been achieved [14]. As
treatment programs continue to expand, identifying and
targeting hard-to-reach populations will be increasingly
important.
We determined the current quantitative evidence-base
on equity in utilization of antiretroviral therapy (ART)
among HIV-infected people in South Africa. This infor-
mation may provide insight into methods used for equity
research and may help policy makers to identify and tar-
get hard-to-reach populations.Methods
We performed a systematic review on the basis of the
Cochrane Handbook for Systematic Reviews of Interven-
tions, Version 5.1.0.4 [15]. Our search was performed on
18 February 2013 using Pubmed, Embase, Central and
Psychinfo database. Our search syntax consisted of
search terms in four categories (ART, HIV, South Africa
and Equity), that were combined using AND. The searchTable 1 Search strategy employed in systematic review of stu
Category Search terms (in Pubmed database)
ART Antiretroviral therapy, highly active [MeSH Terms] OR ART [tit
OR ARVs [title/abstract] OR Anti-Retroviral Agents [Mesh] OR a
OR anti-retroviral [title/abstract] OR antiviral [title/abstract] OR
AND
HIV Acquired immunodeficiency syndrome [MeSH Terms] OR acq
[title/abstract] OR hiv [MeSH Terms] OR hiv [title/abstract] OR
infections [MeSH Terms]
AND
South Africa (South Africa [MeSH Terms] OR (South [title/abstract] AND Af
AND
Equity (Equity [title/abstract] OR equities [title/abstract] OR inequity
equalities [title/abstract] OR equal [title/abstract] OR equitable
OR unequal [title/abstract] OR disparity [title/abstract] OR disp
[title/abstract] OR unfair [title/abstract] OR social justice [MeSH
OR barrier [title/abstract] OR coverage [title/abstract] OR barri
services accessibility [MeSH Terms] OR health services accessistrategy is presented in summary in Table 1 and in detail
in Additional file 1.
Conceptual model
Following the WHO’s guidance on monitoring equity in
AIDS treatment programs [16], we distinguished five do-
mains of coverage: 1) availability of resources; 2) physical
and financial accessibility; 3) acceptability; 4) use of ser-
vice; and 5) effective coverage (defined as the proportion
of the population in need of an intervention who fully
comply with the recommended treatment program).
This review focuses on the latter two domains as the
other domains feed into these. We included studies on
both ART initiation and adherence and this was together
labeled as ‘ART utilization’. We acknowledge that an in-
dividual’s health care utilization can be explained by a
function of predisposing factors (e.g. education, culture,
health beliefs, age and sex), enabling factors (income,
health insurance, waiting time, genetic factors) and need
factors (perceived need to seek and adhere to care and
professional’s judgment about people’s health status)
[17]. We used the terms ‘equity’ and ‘inequity’ to reflect
differences in utilization of ART by criteria such as se-
verity of disease, age, or SES [18].
Inclusion and exclusion criteria
A study was included if it: 1) compared for different
groups of HIV infected people (by sex, age, severity of
disease, area of living, socio-economic status, marital
status, ethnicity, religion and/or sexual orientation (i.e.
equity criteria (World Health Organization, Guidance on
Priority Setting in Health Care (GPS health) in prepar-
ation) [19]) the number initiating/adhering to ART with
the number who are not); 2) was performed in South
Africa; and 3) reported in English. Although some equity
criteria are the social determinants of health, severity ofdies on equity in ART utilization in South Africa
le/abstract] OR HAART [title/abstract] OR AR V [title/abstract]
ntiretroviral [title/abstract] OR anti retroviral [title/abstract]
therapy [title/abstract]
uired immunodeficiency syndrome [title/abstract] OR aids
human immunodeficiency virus [title/abstract] OR HIV
rica* [title/abstract]))
[title/abstract] OR inequities [title/abstract] OR equality [title/abstract] OR
[title/abstract] OR inequality [title/abstract] OR inequalities [title/abstract]
arities [title/abstract] OR vulnerability [title/abstract] OR fairness
Terms] OR social justice [title/abstract] OR justice [title/abstract]
ers [title/abstract] OR healthcare disparities [MeSH Terms] OR health
bility [title/abstract] OR access to health care [title/abstract])
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‘equity criteria’ which was put forward by the WHO
[World Health Organization, Guidance on Priority Setting
in Health Care (GPS health) in preparation] and Tromp
et al. [19]. A study was excluded if it: 1) focused on preven-
tion of mother to child transmission (PMTCT), death dur-
ing follow up, barriers of accessing care or tuberculosis
(TB) services for HIV infected patients; 2) was a qualitative
study, comment, editorial, economic evaluation or confer-
ence abstract; 3) was a duplicate reference from different
databases; and 4) reported only differences in groups by a
simple comparison with the gross number of people initiat-
ing or adhering to ART. We only included studies that take
into account the underlying need of a group for ART. For
example, the mere fact that more women than men have
access to ART does not necessarily indicate an inequity as
more women than men may be infected in the country.
There was no restriction for publication date for inclusion
of studies. Following the Cochrane guidelines grey literature
was excluded due to expected low methodological quality
of studies [15].
Study selection, data extraction and quality evaluation
Two independent reviewers (CM and EM) assessed if
the studies from the database search satisfied the inclu-
sion criteria. First, all studies were screened on the basis
of title and abstract, and subsequently on the basis of
full-text. Reference lists of the retrieved articles were
screened for additional studies (snowballing). The re-
viewers used a data collection form (Additional file 2) to
extract relevant information (study characteristics, re-
sults per equity criteria, and study limitations) from the
articles. Both reviewers evaluated the quality of studies
using a quality-grading protocol (Additional file 2)
adapted from existing protocols [15,20,21]. The proto-
col covers 20 indicators and for each item 0–2 points
are given and added up to get an overall quality score
(ranging from 0 to 40 points). Studies were categorized
as low-quality (<20 points), medium-quality (20–29) or
high-quality (≥30). During the study selection, data
extraction and quality assessment, disagreements were
resolved through discussion with a third researcher
(NT) until consensus was reached.
Data synthesis and analysis
A matrix was developed containing the study results per
investigated equity criterion. We established the follow-
ing categories to summarize the results for each equity
criteria investigated in a study: 1) associated, differences
reported in ART utilization between groups (e.g. men ver-
sus women for sex) were significant (p < 0.05, or when 1.0
does not fall in 95% confidence interval (95% CI)); 2) not
associated differences reported in ART utilization between
groups were not significant (p value >0.05 or 1.0 falls in95% CI; contradicting results, within one study contradicting
results were reported for differences in ART utilization
between groups due to the use of multiple outcome
measures for an equity criterion (e.g. CD4 cell count
levels and WHO disease stages for the equity criterion
severity of disease); and inconclusive results, differences in
ART utilization between groups was investigated but the
authors drew no conclusions due to small sample sizes.
We adhered to the PRISMA guidelines for reporting
of this systematic review [22].
Results
Study inclusion
From the initial search (801 articles), 268 studies were du-
plicates, 483 studies were excluded on the basis of title/ab-
stract and 39 on the basis of full-text screening. Screening
of the references of the remaining 11 studies resulted in
one extra article and added to a total of 12 studies that are
included in this review (Figure 1, Table 2).
Characteristics of included studies
Seven studies assessed inequities in ART initiation (Table 3)
and five studies in ART adherence (Table 4). All studies
were based on primary data analysis from observational
surveys, except for one study using secondary data [23] and
one review [24]. Studies defined ART initiation differently,
like ‘at least 14 days on ART’ [25] or ‘visited the ART clinic
at least once after testing HIV positive’ [26]. Definitions of
non-adherence were also varied, and were measured in
terms of patients’ absence at the clinic for more than one
[27] three [28,29] or six [30] months, or in terms of the
number of pills not taken and brought back to the clinic
(clinic-based pill counts) [31]. The outcome measure used
for equity criteria varied widely among studies. For severity
of disease, some compared the differences in utilization of
ART by WHO disease stages [26-29,31], while others used
CD4 cell count levels [26-31] or viral load [28,31]. For age,
many different age categories were used. Fatti et al. [29]
only included children in the study population, and the old-
est age group in that sample is younger than the youngest
age group in for example Govindasamy et al. [26] (who
compared people below and above 30 years of age). Six
studies, all using different databases, investigated urban and
rural areas of the Western cape province and two studies
reported at the national level [23,24]. More than half of the
articles (seven) [25-27,29-32] were of high-quality, three
had medium-quality [28,33,34] and two were of low-quality
[23,24]. Table 5 gives an overview of the quality scoring per
study.
Equity in utilization of ART
For sex, two [24,27] out of ten studies [24-33] that
reported on this equity criterion found an association
between sex and utilization of ART. In both studies
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Figure 1 ‘Flow diagram showing study selection for systematic review of studies on access to antiretroviral therapy in South Africa’.
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utilization of ART compared to women. The other eight
studies (six high- and two medium-quality) found no as-
sociation [25,26,28-33].
Four [30-33] (three high and one medium-quality) out
of eight studies [26–33] reported that relatively young
people have a lower utilization of ART. The other four
studies (three high- and one medium-quality) that re-
ported on age found no association [26-29].
For severity of disease, five [26-29,31] out of six
studies [26-31] reported contradicting results. In four
[26-28,31] out of these five studies an association was
found between ART utilisation and a person’s CD4 cell
level while no association was found with a patient’s
WHO status. Of these studies, one ART initiation [26]
and one on adherence [27] (both high quality) reported
that higher CD4 cell counts are associated with lower
utilization of ART. On the contrary, two other studies
on adherence (one high- and one medium-quality) re-
ported that lower CD4 cell count is associated with less
utilization [28,31]. In one other study (high quality) that
reported contradicting results for severity of disease
among children, an association was found with WHO
stage but not with CD4 cell count level [29]. The sixth
study (high quality) reporting for severity of disease,
only looked at CD4 cell count levels and found that
patients with a higher CD4 cell count level adhered
less to ART [30].For area of living, three [23,29,34] out of the four stud-
ies [23,29,32,34] that reported on this criterion found an
association between area of living and ART utilization.
Two studies (high- and medium-quality) reported that
people in certain provinces have lower utilization of
ART (seeTable 3) [23,34]. One of the studies (high-quality)
reported that children living in rural areas and who visit
ART clinics in urban areas, have lower utilization than
children that visit clinics in their own area of living (urban
or rural area) [29]. The fourth study (high-quality) that
reported on area of living found no association between
ART utilization and area of living (peri-urban, urban or
rural area) [32].
Socioeconomic status was found to be associated with
ART utilization in two [28,33] (both medium-quality)
out of the six studies [25,26,28,31-33] that reported on
this criterion, which showed that those unemployed have
lower utilization of ART. One of these two studies also
reported that those with lower education utilize less
[33]. Of the four studies that found no association, one
(high-quality) found no differences on the basis of
employment and education [26]. The other three (all
high-quality) found no differences in ART utilization
between those with differences in SES [25,31,32]. One
of these also found no association between educational
level and ART utilization [32].
For marital status only one study (medium-quality)
was included in this review and reported that being
Table 2 Overview of reported findings per study on association between equity criteria and ART initiation or adherence
Reference Equity criteria
Name, year Quality
score
Sex Age Severity of disease Area of living Socio-economic status
(including education and
employment)
Marital status Ethnicity
ART initiation (lower < higher likelihood to initiate)
Cleary
2011 [25]
*** Not
associated,
men =
women
SES: not associated,
SES distribution HIV +
in need = ART clinic patients
Inconclusive results
population size too small
to draw conclusions
Cooke
2010 [32]
*** Not
associated
men =
women
Associated, younger
(15–19 yrs), < older
(>19 yrs)
Not associated, peri-
urban = urban = rural
SES: not associated, index
profile 1 = 2 = 3 = 4 = 5 (SES),
education: not associated,
years of education as
continuous variable
Govindasamy
2011 [26]
*** Not
associated,
men =
women
Not associated,
≤ 30 yrs = ≥ 30 yrs
Contradicting results,
CD4 cell count: associated,
CD4 > 350 < ≤350,
WHO stages: not associated
Education: not associated,
primary school completed =
not completed, employment:
not associated,
employed < unemployed
Tsai
2009 [33]
** Not
associated,
men =
women
Associated, younger
(18–30 yrs) < older
(30–35 yrs)
Education: associated,
lower education
(secondary) < higher
education (matric/ tertiary),
employment: associated,
non salaried employment
< salaried employment,
unemployed < employed
Associated never
married <married
or cohabiting
Adam
2009 [34]
** Associated4, unequal
ART coverage
between 9 provinces
Muula
2007 [24]
* Associated4,
male <
female
Nattrass
2006 [23]
Associated4, unequal
ART coverage
between 9 provinces
ART adherence (poorer < better adherence)
Boyles
2011 [30]
*** Not
associated,
men =
women
Associated, younger
(<25 yrs) < older,
(25–50 yrs)
Associated, CD4≥ 200
< <200
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Table 2 Overview of reported findings per study on association between equity criteria and ART initiation or adherence (Continued)
Orrell
2003 [31]
*** Not
associated,
men =
women
Associated, younger
< older, adherence
group is older (34 yrs)
than non-adhererce
group (31 yrs)
Contradicting results,
CD4 cell count: associated,
patients that not adhere
had lower CD4 level, Viral
load: associated, patients
that not adhere had higher
VL, WHO stage: not associated
SES: not associated,
% low SES in patient
group that continued,
ART = that not
continued
Kranzer
2010 [27]
*** Associated,
men <
women
Not associated,
≤ 30 yrs = > 30 yrs
Contradicting results, CD4
cell count: associated, > 200
<≤100, WHO stage:
not associated
Fatti
2010 [29]
*** Not
associated,
men =
women
Not associated,
younger children
(≤2 yrs) = older
children (>2 yrs)
Contradicting results,
CD4 cell count (severe
immunodeficiency1):
associated, patients
with severe i
mmunodeficiency
were less adherent,
WHO stage (severe
clinical status2):
not associated
Associated, rural/
urban < urban/urban
< rural/rural3
Cornell
2009 [28]
** Not
associated,
men =
women
Not associated,
age as continuous
variable
Contradicting results,
CD4 cell count: associated,
CD4 < 50 < 50–150, but CD4
< 50 = >150, WHO stage:
not associated, Viral load:
not associated
Employment: associated,
no income < income
ART = antiretroviral therapy, LTFU = lost to follow up, SES = socio-economic status, VL = viral load, WHO =world health organization.
1defined according to WHO criteria, i.e. < 12 months old: CD4 percentage <25% or CD4 count <1500 cells/mm3; 12–35 months: <20% or CD4 count <750; 36–59 months: CD4 percentage <15% or CD4 count <350;
5 years and older: CD4 count <200.
2defined as a WAZ score of < −3 (severe underweight) or a WHO stage ≥3.
3rural/urban, urban/urban, rural/rural = first term indicates place of residence and second the area of accessing ART clinic.
4no significance was reported and authors concluded that ART utilization was different among groups that were compared.
* = low quality, ** = medium quality, *** = high quality.
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Table 3 Overview of finding per study reporting on equity in ART initiation
Study, quality
score, study
type
Study objective Study area, type of clinic/
program
Year of data
collection
Study design (comparison
between population a and b),
population sizes, sampling
method/inclusion criteria
Statistical
analysis
Outcome on association
as reported per equity criteria
Cleary
2011 ***
Observational
[25]
To evaluate whether the
distribution of ART services
in the public system reflects
the distribution of people in
need among adults in the
urban population
Urban area: poor
communities in Mitchells
Plain (Cape Town, Western
Cape province) and Soweto
township (Johannesburg,
Gauteng province), public clinics
National
survey: 2008.
Urban clinic
data:
unknown
a. Population in need for ART
(n = 742): national survey (2008,
HIV + residents), sampling unknown,
Comparison
distribution of
equity criteria
(i.e. patients
characteristics)
Sex (not associated): percentage of HIV +
women in national survey is same as in
ART users in urban clinic; 67.4% [95% CI:
61.5-72.9] versus 65.7% [95% CI: 60.6-70.7],
p >0.05. Socioeconomic status (not
associated): no significant differences
in SES distribution between HIV + in
need for ART and ART patients in urban
clinics; independence partition Pearson’s
chi-square test: 8 [p = 0.43] Race/ethnicity
(inconclusive results): percentage of
non-African is 2,5% in population HIV +
in need versus 4.3% of ART users in
urban clinics, authors state that sample
size of non-African is too small to draw
conclusions on equity
b. ART patients in urban public
clinics (n = 635): data from ART
users (>18 yrs, >14 days on
treatment) in three clinics in
Mitchells Plain (selected
proportional to the number
of ART patients in facility) and
three in Soweto (stratified
random sampling)
Cooke
2010 ***
Observational
[32]
To investigate factors
associated with uptake
of ART through a primary
health care system in rural
South Africa
Rural, peri-urban and urban
areas: Hlabisa sub-district,
Umkhanyakude district, Northern
KwaZulu-Natal province, public
clinics supported by NGOs
Aug 2004 –
Dec 2008
a. HIV + residents not on ART
(n = 1,003): population-based
surveillance in 6 catchment areas,
Multivariate
logistic
regression
Sex (not associated): no significant
association between gender and
receiving treatment: aOR men 0.875
[95% CI: 0.708-1.081, p = 0.216] Age
(associated, younger (15–19 yrs)
< older (>19 yrs)): compared to age
15–19 (reference) all higher 5-year-age-
groups [20–24, 25–29, 30–34, 35–40,
40–45, 45–50, 50–54, 55–60, >60] have
significant higher aOR [ranging between
4.9-14.0, p < 0.05] for receiving treatment
Area of living (not associated): no
significant differences in aORs between
peri-urban [1.042, 95% CI: 0.699-1.554,
p = 0.838], rural [0.941, 95% CI:
0.628-1.410, p = 0.768] and urban
(reference) areas for receiving treatment
Socioeconomic status (not associated):
no significant differences in aORs between
index profiles 1 (reference), 2 [0.932, 95% CI:
0.688-1.262, p = 0.649], 3 [0.842, 95% CI:
0.624-1.135, p = 0.258], 4 [0.829, 95% CI:
0.607-1.131, p = 0.237] and 5 [0.984, 95% CI:
0.702-1.379, p = 0.927] for receiving treatment
Education (not associated): no significant
association between years of education and
receiving treatment; aOR years of education:
1.022 [95% CI: 0.995-1.063,
p = 0.128]
b. HIV + residents on ART
(n = 1,251): population based 2008
cohort (HIV+, > 15 yrs, on ART)
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Table 3 Overview of finding per study reporting on equity in ART initiation (Continued)
Govindasamy
2011 ***
Observational
[26]
To assess the proportion and
characteristics of individuals
who accessed HIV care after
testing HIV + in a mobile
testing unit
Rural area: Cape Metropolitan
region, Western Cape province,
type of clinic not clearly
reported
Tested HIV+:
2008–2009.
Interviewed:
Apr-Jun
2010.
Patients tested HIV + in mobile
testing units that: a. linked to
ART care (i.e. receiving CD4
test result), b. not linked,
A random sample of patients
tested HIV + between August
2008 – December 2009,
≥18 yrs, CD4 < 350, received
CD4 test results, available
socio-demographic variables
was selected using mobile
testing unit records (n = 77)
Binomial
univariate and
bivariate
regression
analysis
Sex (not associated): same likelihood to
link to care for female as male patients;
**RR female: 1.18 [95% CI: 0.81-1.72,
p = not reported, 1.0 falls within CI] Age
(not associated): same likelihood to link
to care for younger (≤30 years) as older
patients (≥30 years) to link to care; **RR
≥30 years: 1.21 [95% CI: 0.83-1.77, p = not
reported, 1.0 falls within CI] Severity of
disease (contradicting results, CD4 cell
count associated and WHO stages not
associated): significantly lower likelihood
to link to care for patients with high
(>350) compared to low (≤350) CD4 cell
count;*RR CD4 > 350: 0.49 [95% CI: 0.27-0.87,
p = 0.014] / same likelihood to link to care
for patients in WHO stage I as WHO stage II,
III or IV; **RR WHO clinical stage I: 0.88
[95% CI: 0.65-1.18, p = not reported, 1.0 in CI]
Education (not associated): same likelihood
to link to care for patient completed primary
school as patients that have not; **RR
completed primary school: 1.17 [95% CI:
0.66-2.08, p = not reported, 1.0 falls
within CI] Employment (not associated,
employed < unemployed): likely lower
likelihood to link to care for employed
compared to unemployed patients; **RR
employed: 0.72 [95% CI: 0.51-1.01, p = 0.056].
* = univariate ** = bivariate analysis
Tsai 2009 **
Observational
[33]
To assess differences in
socioeconomic profiles
between those who access
HIV-related clinical services
and the HIV-infected
individuals living in the
wider community
Rural area: Limpopo
province, public hospital
Community
survey: 2004-
2005. Clinic
survey: Jan
2003 – Nov
2005
a. community sample,
HIV + not on ART
(n = 242): household
survey, random sampled
from eight rural villages in
the province (14–35 yrs, HIV+),
Uni-variate
comparison
and multiple
regression
Sex (not associated): no significant
difference percentage women in the
community vs. clinic sample: 79%
vs. 79% [p = 0.78] Age (associated,
younger (18–30 yrs) < older (30–35 yrs)):
significant difference in age distribution
between community and clinic sample:
18–20 yrs: 13% vs 3.6%; 21–25 yrs: 33%
vs. 16%; 26–30 yrs: 36% vs 33%;
31–35 yrs: 18% vs. 47%; X2 = 85 [p < 0.001*]
Education (associated, higher
education > lower education): significant
difference in distribution educational
attainment between community and clinic
sample: in clinic less likely to completed
secondary education [p < 0.001], but more
likely to completed matric or tertiary
education [p = 0.04] X2 42 [p < 0.001*]
Employment (associated, not having
salaried employment < having salaried
employment, unemployed < employed):
b. clinical sample, HIV + on
ART (n = 534): convenience
sample of patients (18–35 yrs)
in primary HIV/AIDS provider
hospital, referred by 45 primary
health care clinics. Note: samples
were not taken from identical
sub-districts
Trom
p
et
al.InternationalJournalfor
Equity
in
H
ealth
2014,13:60
Page
8
of
17
http://w
w
w
.equityhealthj.com
/content/13/1/60
Table 3 Overview of finding per study reporting on equity in ART initiation (Continued)
significant difference percentage having
salaried employment between community
and clinic sample: 6.2% vs. 11%, X2 3.8
[p = 0.05] and in percentage unemployed
and able to work: 57% vs. 37%; X2 26
[p < 0.001*] Marital status (associated,
never married <married or cohabiting):
significant difference distribution marital
status between community and clinic
sample: never married: 78% vs. 43%;
married/ cohabiting: 16% vs. 30%; X2
83 [p < 0.001*] *also significant after
multivariable regression
Adam 2009 **
Observational
[34]
To quantify the coverage
in South Africa up to the middle
of 2008, according to various
definitions of antiretroviral
treatment eligibility
Rural and urban: National/
nine provinces, public clinics
2008 For nine provinces: a. number of
HIV + in need for ART: Markov
model on HIV progression using
different CD4 count compartments
Comparison
ART coverage
data
Area of living (associated, unequal
coverage among nine provinces): unequal
ART coverage in 2008 among 9 provinces:
Eastern Cape 32.4%, Free State 25.8%,
Gauteng 43.5%, KwaZulu-Natal 39.4%,
Limpopo 32.2%, Mpumalanga 31.2%,
Northern Cape 61.1%, North West 35.4%,
Western Cape 71.1%
b. number of HIV + on ART:
estimates of patients starting ART in
public health facilities using
Department of Health unpublished
internal report (7 May 2009)
Muula 2007 *
Systematic
review [24]
To describe the gender
distribution of patients
accessing ART in
Southern Africa
Rural and urban: National
(1999–2004), Khayelisha township
in Capetown (2001–2), Eastern
cape province 2001–4), Northern
cape province
(2001–5), public clinics
2000 – 2006 a. National HIV + prevalence
female/male ratio in 2005,
Comparison
female/male
ratios
Sex (associated, male < female): female
have higher access than men to ART: HIV
prevalence female/male ratio = 1.2, while
4 studies report access to ART female/male
ratio of 1.9, 2.3, 1.8 and 1.5
b. access to ART female/male
ratio. Sampling methods not
reported
Nattrass 2006 *
Critical
assessment [23]
To compare ART roll-out
in public sector between
provinces in 2003-2005
Rural and urban: National
(nine provinces), public clinics
2003 - 2005 For nine provinces: Comparison
ART coverage
data
Area of living (associated, unequal
coverage among 9 provinces): unequal
ART coverage at the end of 2005 among 9
provinces: Eastern Cape 21.8%, Free State
21.0%, Gauteng 29.6%, KwaZulu-Natal
20.0%, Limpopo 27.3%, Mpumalanga 20.9%,
Northern Cape 32.3%, North West 24.5%,
Western Cape 55.7%
a. number of HIV + in need
for ART,
b. number of HIV + on ART,
estimates of ART coverage based
on ASSA2003 demographic model
(includes public, NGOs and private
sector providers)
CI = Confidence Interval, aOR = adjusted odds ratio, ART = antiretroviral therapy, WHO =world health organization. * = low quality, ** = medium quality, *** = high quality.
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Table 4 Overview of findings per study reporting on equity in ART adherence
Study, quality
score, study
type
Study objective Study area, type of
clinic/program
Year of
data
collection
Study design (comparison between
population a and b), population
sizes, sampling method and
inclusion criteria
Statistical
analysis
Main outcome of analyzed equity
criteria
Boyles 2011 ***
Observational
[30]
To determine the factors predicting
loss to follow-up and mortality in a
public-sector HIV and ART
programme in rural South Africa
Rural area: Elliotdale/
Xora area of Mbhashe
sub-district in Eastern
Cape province,
combined public/donor
program
Jan 2005 –
Sept 2009
a. HIV + patients that loss to
follow up (n = 117 (6.5%)),
Multiple Cox
proportional
hazard
regression
Sex (not associated): females and males
have same risk of being loss-to-follow-up:
HR female: 1.42 [95% CI 0.90-2.23,
p = 0.134] Age (associated, younger
(<25 yrs) < older (25–50 yrs)): younger
people have significant higher risk
to loss-to-follow-up: HR <25 yrs (compared
to 25–50 yrs): 1.87 [95% CI: 1.15-3.05,
p = 0.012] Severity of disease (associated,
≥ 200 CD4 < <200 CD4): higher CD4 cell
count significantly increases risk to
loss-to-follow-up: 50–199 CD4 (referent);
HR 0–49 CD4: 1.00 [95% CI: 0.61-1.64,
p = 0.019]; HR≥ 200 CD4: 1.74 [95% CI
1.09-2.78, p = 0.019]
b. HIV + patients that do not loss
to follow up (n = 1686). Both
groups are patients enrolled in
clinics of Madwaleni HIV wellness
and ART program including
adherence counseling and home
visits (i.e. Madwaleni Hospital,
its 7 primary healthcare feeder
clinics and a community based
outreach program): tested HIV+,
ART naïve at time of study
enrollment, >19 years, initiated
ART (CD4 < 200 CD4), could be
follow for at least 3 months
(n = 1803)
Orrell 2003 ***
Observational
[31]
To determine adherence of an
indigent African HIV-infected cohort
initiating ART to identify predictors
of incomplete adherence and viro-
logic failure
Urban area: Cape Town,
Western Cape province,
university of Cape
Town clinic
Jan 1996 –
May 2001
a. Patients discontinued
48 weeks of ART (n = 47),
T-test (age, VL,
CD4 cell
count), X2 test
(gender,
socioeconomic
status)
Sex (not associated): no significant
difference in percentage female between
those discontinued (40.4%) and completed
(43.4%) 48 weeks of ART [p = 0.7] Age
(associated, younger < older): those
discontinued ART before 48 weeks were
significantly younger (31 yrs) than those
completed (34.1 yrs) [p <0.005] Severity of
disease (contradicting results, CD4 cell
count associated and WHO stages not
associated): those discontinued ART before
48 weeks had significantly lower mean CD4
cell count (197) than those completed
(268) [p < 0.01] / those discontinued before
48 weeks ART had a significantly higher VL
(5.71 log10) than those completed (5.49
log10) [p <0.05] / no significant difference
in percentage WHO stage 3 or 4 between
those discontinued (49.2%) and completed
(38.2%) 48 weeks of ART [p = 0.2] Socio-
economic status (not associated): no
significant difference in the percentage of
patients with low socio-economic status in
the group that discontinued (36.2%) and
completed (43.6%) 48 weeks of ART
[p = 0.4]
b. Patients that completed
48 weeks of ART (n = 242).
Both groups are from Cape
Town AIDS Cohort (CTAC):
HIV + patients, presenting at
University of Cape Town HIV
clinics (referred by health care
workers in the public sector of
the wider Cape town area,
mainly serving indigent
populations), were ART
naïve and eligible for
adherence monitoring
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Table 4 Overview of findings per study reporting on equity in ART adherence (Continued)
Kranzer
2010 ***
Observational [27]
To investigate the frequency and
risk factors of defaulting treatment
and identify factors associated with
subsequent return to care in a
long-term treatment cohort in
South Africa
Peri-urban: township in
Cape Town, Western
Cape province, public
clinic
Mar 2004 -
Dec 2009
a. HIV + patients that defaulted
ART (n = 291),
Multiva
Poisson
regress
Sex (associated, men <women):
compared to women, men have a
significant increased risk to default ART
treatment, HR men: 1.51 [95% CI: 1.18-1.93,
p < 0.01] Age (not associated): no
significant association between age and
defaulting treatment, compared to younger
age (≤30 years), HR > 30 years: 0.90 [95% CI:
0.70-1.15, p = 0.40] Severity of disease
(contradicting results, CD4 cell count
associated and WHO stages not associated):
higher CD4 cell count increases significantly
risk for defaulting treatment, ≤100 CD4
(referent); 101–200 CD4: HR 1.32 [95% CI:
0.99-1.76, p = 0.06], CD4 > 200 HR: 1.39 [95%
CI 1.02-1.91, p = 0.04]. No significant
difference in the risk of defaulting treatment
being in WHO stage 3/4 or 1/2, HR stage 3/4:
1.14 [95% CI: 0.85-1.53, p = 0.37]
b. HIV + patients that not
defaulted ART (n = 863). Both
groups are from patients presenting
at public-sector primary care clinic
(single ART server in the area),
>15 years, started ART (until
2007 < 350 CD4 cells (NIH
research study), after 2007
< 200 CD4 cells (provincial
ART program) (n = 1154)
Fatti
2010 ***
Retrospective
cohort study [29]
To compare clinical, immunological
and virological outcomes between
rural and urban children on ART in a
large cohort from multiple public
health facilities in four provinces of
South Africa
Rural and urban: areas
in Western Cape,
KwaZulu-Natal, Eastern
Cape and Mpumalanga
province, public clinics
supported by NGOs
Nov 2003 –
Mar 2008
a. Children on ART that loss to
follow up (n = 179),
Multiva le
Cox
proport l
hazards
regress
Sex (not associated): gender is not
associated with risk of LTFU: HR male: 1.1
[95% CI: 0.82-3.12, no p value reported, 1.0
falls within CI] Age (not associated):
younger children (<2 yrs) are as likely to
LTFU than older children (>2 yrs): > 2 yrs
(referent); HR 1–2 yrs: 1.61 [95% CI: 0.96-
2.68, no p value reported, 1.0 in CI > 0.90];
HR < 1 yr: [1.81, 95% CI: 0.94-3.64, no p
value reported, 1.0 in CI] Severity of
disease (contradicting results, CD4 cell
count not associated and WHO stages
associated): severe clinical status is
associated with risk LTFU: HR severe clinical
status: 1.47 [95% CI: 1.03-2.12, no p value
reported, 1.0 not within CI]/ severe
immunodeficiency was associated with risk
LTFU: HR severe immunodeficiency: 0.81
[95% CI: 0.52-1.24, p value not reported, 1.0
in CI Area of living (associated, rural/
urban < urban/urban
< rural/rural): patient in rural areas visiting
clinics in urban areas are more likely to
LTFU than patients from rural areas visiting
rural clinics and patients in urban areas
visiting urban clinics: rural (referent); HR
urban: 1.14 [95% CI: 0.57-2.24]; HR rural/
urban 2.85 [95% CI, 1.41-5.79] [p = 0.004]
b. Children on ART that do
not loss to follow up (n =
2153). Both from retrospective
cohort of children, (<16 yrs, ART
naïve), enrolled in 44 routine
public healthcare facilities
(7 rural, 33 urban/12 secondary
level hospitals, 32 primary health
care clinics) supported by a NGO,
used electronic data collection
systems for patient monitoring.
Children were divided in
3 groups a) urban residence
and urban ART facility attended
(urban group, n = 1727); rural
residence and rural facility
attended (rural group, n = 228);
and rural residents attending urban
facilities (rural/urban group, n = 377)
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Table 4 Overview of findings per study reporting on equity in ART adherence (Continued)
Cornell
2009 **
Observational
[28]
To investigate the impact of gender
and income on survival and
retention in a South African public
sector ART programme
Urban: Nyanga township,
outskirts of Cape Town,
Western Cape province,
public clinics supported
by NGOs
Sept 2002
– Apr 2007
a. HIV + patients that loss to follow
up (n = 137),
Proportional
hazards
regression
models
Sex (not associated): gender is not
associated with risk to LTFU: HR men: 1.38,
[95% CI: 0.94-2.03, p = 0.100] Age (not
associated): no significant difference
between age and risk to LTFU: HR age: 0.98
[95% CI 0.96-1.00,
p = 0.102] Severity of disease
(contradicting results, CD4 cell count
associated and WHO stages not
associated): patients with CD4 cell count
<50 have higher risk to LTFU than CD4 cell
count 50–150, but a similar risk as CD4 >
150: CD4 < 50 (referent); HR CD4 51–100: 0.62
[95% CI: 0.37-1.05, p = 0.077]; HR CD4 101–150
[0.57, 95% CI: 0.33-1.00, p = 0.049]; HR CD4 >
150: 1.01 [95% CI: 0.64-1.59, p = 0.971]/ WHO
stage has no association with risk to LTFU:
WHO stage I & II (referent); HR stage III: 0.78
[95% CI: 0.50-1.21, p = 0.274] HR stage IV:
0.75 [95% CI 0.75 (0.44-1.28), p = 0.294] /VL
was not significantly associated with risk to
LTFU: HR RNA level <5 log10 copies/ml
(referent); >5 log: 1.13 [95% CI: 0.78–1.64,
p = 0.520] Employment (associated, no
income < income): patient with no income
have a increased risk to LTFU: HR with
income: 0.53 [95% CI: 0.37-0.77, p = 0.002]
b. HIV + patients that do not loss
to follow up (n = 2059). Both groups
from Gugulethu clinic patient cohort
that receive adherence counseling
including home visits, >15 years, ART
naïve, WHO stage IV or CD4 < 200
(n = 2196)
CI = confidence interval, HR = hazard ratio, ART = antiretroviral therapy, WHO =world health organization, LTFU = loss to follow up, VL = viral load.
* = low quality, ** = medium quality, *** = high quality.
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Table 5 Overview of quality rating scoring per study
High (30–40 points) Medium (20–29 points) Low (<20 points)
Studies
Kranzer
[27]
Cooke
[32]
Fatti
[29]
Govindasamy
[26]
Boyles
[30]
Cleary
[25]
Orrell,
[31]
Cornell
[28]
Tsai
[33]
Adam
[34]
Muula
[24]
Nattrass
[23]
Total score (out of 40 points) 37 34 34 33 32 31 30 26 26 26 19 12
1 Study design (peer reviewed = 2, other = 0) 2 2 2 2 2 2 2 2 2 2 2 2
2 Well-defined hypothesis/objective/research question? (fully = 2, partial = 1,
not at all = 0)
2 2 2 2 2 2 1 2 2 2 2 1
3 Clear motivation research question? (fully = 2, partial = 1, not at all = 0) 2 2 2 2 1 2 2 2 2 2 2 1
4 Concept clearly defined (e.g. access, equity) (fully = 2, partial = 1, not at all
= 0)
2 1 1 2 2 1 2 0 1 2 0 0
5 Methods well described? (fully = 2, partial = 1, not at all = 0) 2 2 2 2 2 2 1 1 2 2 2 0
6 Main outcomes clearly described? (fully = 2, partial = 1, not at all = 0) 2 2 2 2 1 2 2 2 1 2 2 1
7 Potential sources of bias taken into account? (fully = 2, partial = 1, not at
all = 0)
2 2 2 2 2 2 1 0 0 2 0 0
8 Population and sampling method clearly defined? (fully = 2, partial = 1, not
at all = 0)
2 2 2 2 2 2 2 1 1 0 0 0
9 Type of information used (i.e. sample size, time period) clearly described?
(fully = 2, partial = 1, not at all = 0)
2 2 2 2 1 2 2 1 2 1 1 1
10 Primary data used for key analyses? (yes = 2, no = 0) 2 0 2 2 2 0 2 2 0 0 0 0
11 Survey (household/provider level) data used? (yes = 2, partial = 1, no = 0) 2 2 2 2 2 1 2 2 0 2 0 0
12 Research/subquestion(s) answered? (fully = 2, partial = 1, not at all = 0) 1 2 2 1 2 2 1 1 2 2 2 1
13 Results based on evidence derived from the data analysis? (fully = 2,
partial = 1, not at all = 0)
2 2 2 2 2 1 2 2 2 0 0 1
14 Results credible given the methods, data, and analysis used? (fully = 2,
partial = 1, not at all = 0)
2 2 2 2 2 1 1 1 2 2 0 1
15 Robustness of findings and limitations of method discussed? (fully = 2,
partial = 1, not at all = 0)
2 2 2 1 1 2 2 1 2 1 2 0
16 Findings discuss within context of existing evidence base? (fully = 2,
partial = 1, not at all = 0)
2 2 2 2 2 2 2 2 2 2 2 1
17 Missings clearly described? (fully = 2, partial = 1, not at all = 0) 2 2 1 0 2 1 1 2 0 0 0 0
18 Generalizable to rest of the country? (given sample size) (fully = 2, partial
= 1, not at all = 0)
2 1 2 1 1 0 0 0 1 2 2 2
19 Study subjects asked representative of entire population recruited from?
(yes = 2, no = 0)
0 0 0 0 0 2 2 2 0 0 0 0
20 Study subjects prepared to participate representative of entire population
recruited from? (yes = 2, partial = 1, no = 0)
2 2 0 2 1 2 0 0 2 0 0 0
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[33]. For ethnicity only one study (high-quality) was
found, and it reported inconclusive results due to a
small sample size [25]. None of the included studies
looked at the ART utilization by religion or sexual
orientation.
Discussion
This is the first systematic review that examines equity
in utilization of ART in South Africa and identified 12
studies. It seems that men, young people, those living in
certain provinces or rural areas, people who are un-
employed or with low educational level, or those who are
unmarried have less access to ART. For severity of disease,
most studies used more than one outcome measure for
disease stage and reported within their study contradicting
results. No evidence of inequity in ART utilization by ethni-
city, religion and sexual orientation was found. There were
large heterogeneities in both context (study area, type of
program, time period) and methodology of the studies in
this review.
Only one high- and one low-quality study reported a
significant difference in utilization of ART among men
and women, and eight other studies found no differ-
ences. Although it is encouraging that access to ART seems
mostly equal for both genders, the studies in our review
failed to take the timing of ART initiation into account. Ob-
servational studies from South Africa recently showed that
case-fatality rates among HIV-infected men were substan-
tially higher compared to women in South Africa, most
likely related to late entry into care [35,36]. Late entry by
men can be explained as ART is mainly provided through
primary health care services, and its antenatal care services
frequently serve as an entry- point for HIV treatment for
women.
The findings in some studies which showed that young
age is associated with low utilization raises concerns.
Young people may face more barriers to treatment (like
lack of knowledge about treatment possibilities and
benefits and fear for stigma and discrimination) [32].
Yet, this relationship may be confounded by eligibility,
as older people are more likely to be eligible because of
more advanced disease stages. In addition, many studies
did not cover all ages. As the HIV epidemic in South
Africa is ageing [37,38] it will become increasingly import-
ant to determine ART utilization among elderly, a group
previously neglected in research on ART utilization.
Both area of living and SES did not seem to be associ-
ated with ART utilization. However, the studies looking
at area of living were mostly of low-quality. The studies
by Nattrass et al. [23] and Adam et al. [34] reported
coverage levels for different provinces. However, these
studies used a simple Markov-model to estimate the
need for ART, and it is difficult to determine whetherthe model projections are valid. The study by Fatti et al.
[29] reports on children in four different areas. Lower
utilization for children living in rural areas and accessing
clinics in urban areas can be explained by financial and
non-financial barriers such as the monetary cost of trans-
portation or the opportunity cost of accessing health care
services [33]. Nevertheless, more research is needed in
order to generalize these findings to other areas and
population groups. Finally, Tanser et al. [39] showed
that self-reported visiting of health clinics in a rural
South African area was significantly associated with the
distance between the clinic and home, with greater
distance resulting in lower utilization, yet we did not
include this study because it didn’t specifically concern
ART utilization.
Studies on SES and area of living will likely measure
the same inequities as people in deprived areas might
have lower SES. Tsai et al. [33] found significant evi-
dence of socioeconomic inequities in the uptake of ART
services within a rural and deprived part of South Africa
during the early years of the public sector scaling up of
ART (2003–2005). Poorer households in South Africa
and in sub-Saharan Africa generally have less access be-
cause they face various barriers like cost for transport to
the clinic, knowledge of the benefit of ART treatment
and a lower propensity to seek formal sector treatment
for illness [40,41]. Cleary et al. [25] reported no differ-
ences in SES distribution between those in need and
those accessing ART in urban areas in 2008. This is in
line with the ‘inverse equity hypothesis’ which predicts a
paradoxical worsening of health inequities as effective
new public health interventions first diffuse among the
well-to-do but later also among the poor. Last years
ART has been scaled-up drastically (and now reaches
about 80% of those in need) barriers to access might
have been reduced or removed and those least able to
overcome those initial barriers are now able to use the
services [25]. Yet, still about 20% lacks access to treat-
ment and this group likely faces most barriers. In
addition, if South Africa adopts the new WHO guide-
lines and further expands its ART program new inequities
might appear.
We found contradicting results for severity of disease
as within studies differences in ART utilization were re-
ported for HIV-infected people with different CD4 cell
count levels but not for different WHO disease stages.
Also, some studies reported lower utilization for health-
ier patients while other studies for the most severely ill.
One of the studies by Govindasamy et al. [26] addressed
ART initiation and concluded that those with a CD4 cell
count of >350 are less likely linked to care after testing
HIV positive than those ≤350. This can be explained by
the fact that these patients were not yet eligible for ART
and only needed to enrol in the clinic to monitor their
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do not suffer from symptoms. The other five studies ad-
dressed ART adherence. Boyles et al. [30] and Kranzer
et al. [27] both found that those with higher CD4 cell
count (CD4 > 200) adhere less to ART and this may also
be explained by the fact that individuals who default do
so because they feel better on treatment [42,43]. In con-
trast, Fatti et al. [29] and Orrell et al. [31] found that
most severely ill patients were more likely to lost of
follow-up. One explanation could be that patients
perceived a lack of effectiveness of treatment when ill
or not being able to take the medicine because of symp-
toms [42]. However, the status of patients who are lost
to follow-up is difficult to assess, and it is also likely
that many of those are unregistered deaths, thus
explaining the higher rates among those with advanced
disease.
Only one of the studies looked at marital status and
reported less access for unmarried people. However, this
study was of medium quality as it compared socio-
economic characteristics of a community sample with a
clinic sample which were taken from different areas. For
ethnicity, religion and sexual orientation no evidence
was available and more research is needed to determine
inequities in ART utilization by these criteria. It is likely
that inequities exist on the basis of ethnicity, as the his-
tory of apartheid caused differences in access between
black and white South Africans [44]. Also, among black
Africans differences in access between ethnic groups
like Zulu-speakers, French speaking Cameroonians and
Xhosa speakers likely exist, partly due to differences in
language barriers that they may face when accessing
care [45,46]. Although HIV-prevention services for men
who have sex with men (MSM) are expanding across
the country, there are still several gaps [47,48]. This
group may face barriers in ART access due to fear of
provider stigma and social isolation [49,50]. Low HIV
testing rates are reported among Muslim people in
predominantly Muslim residential areas in Cape Town
[51] and different religions might face different levels of
HIV-related stigma which might cause inequities in
ART utilization [52].
After analyzing the findings of the included studies we
found no patterns of equities or inequities that may be
explained by differences in program design (e.g. NGO or
university supported, public program, availability ad-
herence counselor), time period (e.g. before or after
scale up of ART), target population (e.g. indigent pop-
ulations, children) and study area (e.g. townships, rural
areas). On the other hand, patterns might have been
identified if the number of studies included in this re-
view were higher.
We found only 12 studies which looked at equity
criteria for ART utilization, and two of these were oflow- quality. In addition, all studies differed in context
(year of study, area, study population), methodology, and
outcome measured. Access to ART in South Africa has
evolved quickly over the past decade [53] and inequities
that were reported at the start of the ART scale-up
might no longer be relevant now. Given the incomplete
and mixed evidence base, we call for more rigorous ana-
lysis on equity of ART treatment in South Africa, and be-
yond. We flag three important domains. First, reviewed
studies were based on different samples and this made any
comparison or generalisation difficult to achieve. A national
monitoring system on ART initiation and adherence, which
also registers key criteria such as severity of disease, gender,
age, SES and area of living could fill in this gap. To measure
those in need for ART we recommend using the definition
‘eligible for ART on the basis of the country guidelines’ as
not all HIV-infected people might be already eligible for
ART. Yet, the challenge remains to identify HIV-infected
patients who are in need of treatment but have not yet been
linked to care. Second, most studies only assessed a few
equity criteria. This could be explained by the emphasis in
strategic ART plans worldwide to reduce gender, SES and
area of living inequities [1]. In addition, the recent
health equity monitor launched by the WHO uses a list
of indicators to present a country’s equity profile, but
recommends to differentiate groups on the basis of
SES, gender, area of living and education level only
[54]. We therefore recommend getting similar insights
in inequalities between groups that differ in age, severity of
disease, marital status, ethnicity, sexual orientation and reli-
gion for ART utilization. Third, studies employed a variety
of definitions of both ART initiation and adherence
measures, but also of equity criteria measures, indicat-
ing the need to develop standardized measures in this
area of study.
Conclusions
On the basis of 12 studies identified in this review it
seems that men, young people, those living in certain
provinces or rural areas, those who are unemployed or
with a low educational level, and those who are unmar-
ried are disadvantaged from utilization of ART. For se-
verity of disease, most studies used more than one
outcome measure for disease stage and reported within
their study contradicting results. For ethnicity, religion
and sexual orientation there was no evidence available
to draw conclusions. As studies stem from different con-
texts and use different methods, findings cannot be gen-
eralized and conclusions should be taken with caution.
In order to better inform policy makers, we call for im-
proved guidance in equity research on ART, addressing
the need to develop national monitoring of inequity of
utilization of ART and employing standardized measures
of utilization and equity criteria.
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